Abstract
Early detection of breast cancer has been studied for effectiveness in reducing mortality for more than four decades. During this period numerous studies took place, with more than half a million participating women. In spite of large amounts of nonconflicting data, different countries took varying lengths of time to establish a policy, and came up with a variety of policies, quite different from one another. Inherent differences between the countries in structure of the health system, in the commitment to public health activities, and in opinions and health habits of the relevant populations may explain these different outcomes.
Keywords
- Breast Cancer
- Hormone Replacement Therapy
- Breast Cancer Screening
- Preventive Service Task
- Screen Mammography
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Shapiro S, Venet W, Strax, Venet L (1988) Periodic screening for breast cancer: The Health Insurance Plan Project and its Sequelae, 1963–1986. Baltimore, The Johns Hopkins University Press
Baker LH (1982) Breast Cancer Detection Demonstration Project: five year summary report. Ca Cancer J Clin 32:194–225s
Andersson L, Aspegren K, Janzon L, et al (1988) Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ 297:943–948
Roberts MM, Alexander FE, Anderson TJ, et al (1990) Edinburgh trial of screening for breast cancer. Mortality at seven years. Lancet 335:241–246
Tabar L, Fagerberg G, Duffy SW, et al (1992) Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 30:187–210
Miller AB, Baines C, To T, Wall C (1992) Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. CMAJ 147:1477–1488
Frisell J, Eklund G, Hellstrom, et al (1991) Randomized study of mammography screening-preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 18:49–56
Nystrom L, Rutqvist LE, Wall S, et al (1993) Breast cancer screening with mammography: an overview of the Swedish randomized trials. Lancet 341:973–978
de-Waard F, Collette HJ, Rombach JJ, Baanders van Halewijn EA, Honing C (1984) The DOM project for the early detection of breast cancer, Utrecht, The Netherlands. J Chronic Dis 37:1–44
Verbeek AL, Hendriks JH, Holland R, Mravunac M, Sturmans F, Day NE (1984) Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975–1981. Lancet 1:1222–1224
United Kingdom trial of Early Detection of breast cancer group (1988) 16-year mortality from breast cancer in the United Kingdom Trial of early detection of breast cancer. Lancet 2:411–416
Palli D, Del Turco MR, Buiatti E, Carli S, Ciatto S, Toscani L, Maltoni G (1961) A casecontrol study of the efficacy of a nonrandomized breast cancer screening program in Florence (Italy). Int J Cancer 38:501–504
Miller AB, To T, Baines C, Wall C 2000 Canadian National Breast Screening Study-2: 13 Year results of a randomized trial in women aged 50–59 Years. JNCI 92:1490–1499
Ringash J (2001) Canadian Task Force on Preventive Health Care. Screening mammography among women aged 40–49 years at average risk of breast cancer. CMAJ 164:469–476
Guide to Clinical Preventive Services (1996) Report of the US Preventive Services Task Force, 2nd edn. Williams & Wilkins, Baltimore, pp 73–88.
Recommendations of the Committee of Cancer Experts on Breast Cancer Screening (1992) 6 April. European Commission
Shapiro S, Coleman EA, Broeders M, Codd M, de-Koning H, Fracheboud J, Moss S, Paci E, Stachenko S, Ballard-Barbash R (1998) Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening. Int J Epidemiol 27:735–42
National Institutes of Health. National Cancer Institute (1997) Consensus development conference on screening mammography in women under age 50. L. Gordis, Chairman
NCI-PDQ (1997) Cancer Facts. Research studies on screening mammography
Thomas DB, Gao DL, Self SG, Allison CJ, Tao Y, Mahloch J, et al (1997) Randomized trial of breast self-examination in Shanghai: methodology and preliminary results. JNCI 9:355–365
Semiglazov VF, Sagaidak VN, Moiseyenko VM, Mikhailov EA (1993) Study of the role of breast self-examination in the reduction of mortality from breast cancer. The Russian Federation/World Health Organization Study. Eur J Cancer 29A:2039–2046
Holmberg L, Ekbom A, Calle E, Mokdad A, Byers T (1997) Breast cancer mortality in relation to self-reported use of breast self examination. A cohort study of 450,000 women. Breast Cancer Res Treat 43:137–140
Baxter N, CTFPHC (2001) Should women be routinely taught breast self-examination to screen for breast cancer? CMAJ 164:1837–1846
Gotzsche PC, Olsen O (2000) Is screening for breast cancer with mammography justifiable? Lancet 355:129–134
Olsen O, Gotzsche PC (2001) Cochrane review on screening for breast cancer with mammography. Lancet 358:1340–1342
EBCG editors, Cochrane Collaboration (2002) Screening mammography: setting the record straight. Lancet 359:439–440
Olsen O, Gotzsche PC (2001) Screening for breast cancer with mammography (Cochrane Review). In: The Cochrane Library. Issue 4. Oxford: Update software
Horton R (2001) Screening mammography-an overview revisited. Lancet 358:1284–1285
P.D.Q. Screening and Prevention Editorial Board. January 24, 2002 Expert Panel Cites Doubts on Mammogramls Worth By GINA KOLATA, New York Times, 2002, US
Miettinen OS, Henschke C, Pasmantier MW, Smith JP, Libby DM Yankelevitz DF (2002) Mammographic screening: no reliable supporting evidence? Lancet 359:404–406
Roubidoux MA, Wilson TE, Orange RJ, Fitzgerald JT, Helvie MA, Packer S-A (1998) Breast cancer in women who undergo screening mammography: relationship of hormone replacement therapy to stage and detection method. Radiology 208:725–8
Banks E (2001) Hormone replacement therapy and the sensitivity and specificity of breast cancer screening: a review. J Med Screen 8:29–34
Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S (2001) Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA 285:171–176
Kavanagh AM, Mitchell H, Giles GG (2000) Hormone replacement therapy and accuracy of mammographic screening. Lancet 355:270–274
Seradour B, Esteve J, Heid P, Jacquemier J (1999) Hormone replacement therapy and screening mammography: analysis of the results in the Bouches du Rhone programme. J Med Screen 6:99–102
Stoutjesdijk MJ, Boetes C, Jager GJ, Beex I, Bult P, Herndriks JH, Laheij R, Massuger L, van Die LE, Wobbes T, Barentsz JO (2001) Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. JNCI 18:1095–102
Tilanus-Linthorst MM, Obdeijn IM, Bartels KC, de Koning HJ, Oudkerk M (2000) First experience in screening women at high risk for breast cancer with MR imaging. Breast Cancer Res Treat 63:53–60
Warner E, Plewes DB, Shumak RS, Catzavelos GC, Di Prospero LS, Yaffe MJ, Goel V, Ramsay E, Chart PI, Cole DE, Taylor GA, Cutrara M, Samuels TH, Murphy JP, Narod SA (2001) Comparison of breast magnetic resonance imaging, mammography and ultra sound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 19:3524–31
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Rennert, G. (2003). Political Interpretation of Scientific Evidence — Case Study of Breast Cancer Screening Policies Around the World. In: Senn, HJ., Morant, R. (eds) Tumor Prevention and Genetics. Recent Results in Cancer Research, vol 163. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55647-0_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-55647-0_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62892-4
Online ISBN: 978-3-642-55647-0
eBook Packages: Springer Book Archive